Oncology · 2009 · 25 citations · 0 references
MedicineCell BiologyOncologyCytogeneticsNeoplasiaNeuro-oncologyBrain TumorsCentral Nervous System TumorsTumor MorphologyBenign Intracranial TumorsCentral Nervous System CytologyCytological Ploidy AssessmentDna Content MeasurementFlow Cytometric AnalysisFlow Cytometry Ploidy TestingNuclear Dna QuantificationUnimodal Distribution
Ploidy and proliferative characteristics were estimated by flow cytometry of the nuclear DNA content of 92 human brain tumors. Samples were frozen at -20 degrees C immediately after surgery and single cell suspensions were obtained with a mechanical dissociation technique. Propidium iodide was employed for nuclear DNA staining. Human normal brain tissue was used as internal diploid reference standard. 86% of benign tumors had unimodal DNA distribution with a DNA index (DNA I = modal channel of the G0/1 peak of the studied population/modal channel of the G0/1 peak of the normal brain) usually within the diploid or near-diploid range. 14.0% had aneuploidy, with an additional cell peak having a median DNA I of 1.60. Among malignant tumors, these figures were 61.2 and 38.8% (p less than 0.001). The percentage of S phase cells was higher in malignant (median = 3.6) than in benign tumors (median = 2.0, p less than 0.01), without correlation to histological tumor subtype. Flow cytometry appears to be a useful method for evaluating differences in DNA distribution in tumors of the central nervous system.